Euclidean Capital LLC
CIK 1825034
13F filing for Q2 2026・No. 4,244
- Holdings
- US$439.84M
- Quarter change
- +US$47.53M
- Entries
- 11
- Net bought (estimate)
- +US$9.04M
The quarter change is the holdings' value against the quarter before, price moves included — not what was bought or sold; each institution's page estimates that.
Net bought (estimate)
Each stock's change in shares at the quarter-end price, added up: a new position counts as bought, one sold out as sold, shares held long only. Splits are compared split-adjusted; corporate actions under a new CUSIP are not estimated. An estimate from the filings, not actual trades.
- New 1
- Sold out 0
- Cut 0
- Added 0
- Corporate actions 0
- Unchanged 10
Largest holdings
11 stocks worth US$439.84M, options and bonds left out.
| Stock | This quarter | Shares | Value | Weight |
|---|---|---|---|---|
| VANGUARD INTL EQUITY INDEX FALLWRLD EX US | Unchanged | 3,243,484 | US$271.64M | 61.76% |
| VANGUARD INDEX FDSVALUE ETF | Unchanged | 520,000 | US$113.32M | 25.76% |
| INDAISHARES TRMSCI INDIA ETF | Unchanged | 369,600 | US$18.25M | 4.15% |
| ORIC PHARMACEUTICALS INCCOM | Unchanged | 989,410 | US$10.72M | 2.44% |
| TEAMSHARES INCCOM | New | 1,099,974 | US$9.04M | 2.06% |
| FOGHORN THERAPEUTICS INCCOM | Unchanged | 1,573,761 | US$7.68M | 1.75% |
| PMV PHARMACEUTICALS INCCOM | Unchanged | 2,627,643 | US$3.52M | 0.80% |
| ALECTOR INCCOM | Unchanged | 1,307,858 | US$2.63M | 0.60% |
| SURROZEN INCCOM NEW | Unchanged | 87,696 | US$2.28M | 0.52% |
| TENAYA THERAPEUTICS INCCOM | Unchanged | 1,015,705 | US$750.71K | 0.17% |
Sign in (free) to see its 11 largest holdings and its trades. Sign in
Filings
The quarter's original 13F filings (SEC).
- 13F-HRFiled August 14, 2026SEC ↗
13F covers long positions in US-listed securities only; the data is SEC's, filed within 45 days of the quarter's end.